This inventor holds 6 USPTO granted patents and 3 EPO patents. Top assignees: Mitsubishi Tanabe Pharma Corporation, Kyowa Hakko Kogyo Co., Ltd.. Active years: 1998-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1998-2014
Title: **Yoshikazu Mori: Innovator in Optically Active Compounds**
Introduction
Yoshikazu Mori, an esteemed inventor based in Osaka, Japan, has made significant contributions to the field of organic chemistry. With a portfolio of six patents to his name, he has established himself as a crucial figure in the development of optically active cyclic alcohol compounds.
Latest Patents
Mori's latest inventions focus on the preparation of optically active cyclic alcohol compounds. His patents describe a method for creating an optically active cyclic alcohol compound represented by a specific general formula, where "R" signifies either a hydrogen atom or a protecting group for the amino group, while "*" indicates an asymmetric carbon atom. This work is pivotal for advancements in pharmaceuticals and related applications.
Career Highlights
Throughout his career, Yoshikazu Mori has worked with prominent companies such as Mitsubishi Tanabe Pharma Corporation and Kyowa Hakko Kogyo Co., Ltd. His tenure at these organizations has allowed him to contribute his expertise in the development of innovative compounds that are essential in various therapeutic areas.
Collaborations
Mori has collaborated with notable colleagues, including Masaki Okamoto and Akira Sakuragi. These partnerships have enhanced his research and development efforts, facilitating breakthroughs in the preparation of optically active compounds.
Conclusion
Yoshikazu Mori continues to be an influential innovator in the field of organic chemistry. His contributions through patents and collaborations represent a significant step forward in the preparation of optically active cyclic alcohol compounds, paving the way for further advancements in scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile